产品描述: | Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects. |
靶点: |
Reactive Oxygen Species;Antioxidant; ReactiveOxygenSpecies |
体内研究: |
Succinobucol (50, 100, and 150 mg/kg, i.v.) has no significant effect on either heart rate or MAP, but the blood removed 15 minutes after the final injection of succinobucol shows significantly less aggregation in response to collagen at both 5 µg/mL and 20 µg/mL in rats. Succinobucol (40 mg/kg) by tail injection significantly reduces the average number of metastatic nodules in lung metastatic breast cancer mice |
参考文献: |
1. Houston SA, et al. An investigation of the antiplatelet effects of succinobucol (AGI-1067). Platelets. 2017 May;28(3):295-300. 2. Colle D, et al. Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity. Mol Neurobio 3. Dan Z, et al. A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer. Theranostics. 2016 Jan 25;6(3):435-45. |
溶解性: |
DMSO : ≥ 100 mg/mL (162.10 mM) |
保存条件: |
2-8℃ |
配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
1 mM |
1.621 ml |
8.105 ml |
16.21 ml |
5 mM |
0.324 ml |
1.621 ml |
3.242 ml |
10 mM |
0.162 ml |
0.81 ml |
1.621 ml |
50 mM |
0.032 ml |
0.162 ml |
0.324 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |